Global Celiac Disease Testing Market 2025 by Company, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Celiac Disease Testing market size was valued at US$ 885 million in 2024 and is forecast to a readjusted size of USD 1390 million by 2031 with a CAGR of 6.7% during review period.
Celiac disease is a digestive disorder that causes the body to have difficulty absorbing nutrients like fat, calcium, iron, and folate. It is an autoimmune disease in which gluten-containing foods cause damage to the small intestine lining.Celiac disease is diagnosed using a combination of serologic tests, small bowel biopsy, and a gluten-free diet response. Several serologic antibody tests can be used as initial tests. Antigliadin antibodies are no longer recommended for initial testing due to their low sensitivity and specificity.
The global celiac disease testing market refers to the market for diagnostic tests used to detect celiac disease, an autoimmune disorder where the body’s immune system reacts to gluten, a protein found in wheat, barley, and rye. Celiac disease can cause damage to the small intestine and lead to various symptoms, including gastrointestinal discomfort, malabsorption of nutrients, and other complications.
The market for celiac disease testing includes both laboratory-based tests and point-of-care (POC) tests. Laboratory-based tests involve analyzing blood samples for specific antibodies that are associated with celiac disease, such as anti-tissue transglutaminase (anti-tTG) antibodies, anti-endomysial antibodies (EMA), and anti-deamidated gliadin peptide (anti-DGP) antibodies. POC tests are designed to provide rapid and convenient results at the point of patient care, such as doctor’s offices or pharmacies.
The global celiac disease testing market is driven by several factors, including the increasing awareness and diagnosis of celiac disease, the growing demand for early and accurate detection, and the rising prevalence of the disease worldwide. According to the Celiac Disease Foundation, it is estimated that about 1% of the global population is affected by celiac disease.
In terms of geography, North America dominates the celiac disease testing market, followed by Europe. This can be attributed to the high awareness levels among healthcare professionals and patients, well-established healthcare infrastructure, and the presence of key market players in these regions. However, with increasing awareness and healthcare infrastructure development in emerging economies, such as China and India, the Asia-Pacific region is expected to witness substantial growth in the celiac disease testing market.
Key players in the global celiac disease testing market include diagnostic laboratories, healthcare providers, and companies specializing in diagnostic tests. These companies focus on developing innovative and accurate diagnostic tools for celiac disease, as well as providing comprehensive testing services. Additionally, research efforts are ongoing to discover new biomarkers and improve the efficiency and specificity of celiac disease testing.
Overall, the global celiac disease testing market is expected to experience significant growth in the coming years, driven by factors such as increasing awareness, improving diagnostic technologies, and rising global prevalence of celiac disease.
This report is a detailed and comprehensive analysis for global Celiac Disease Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Celiac Disease Testing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Celiac Disease Testing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Celiac Disease Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Celiac Disease Testing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Celiac Disease Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Celiac Disease Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PRIMA Lab SA, Glutenostics, NanoRepro, Thermo Fisher Scientific, Targeted Genomics, YorkTest, Biohit Oyj, Labsystems Diagnostics Oy, Biomerica, Smartblood, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Celiac Disease Testing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Serologic Tests
Genetic Tests
Intestinal Biopsies
Others
Market segment by Application
Hospitals
Diagnostic Laboratories
Home Care
Others
Market segment by players, this report covers
PRIMA Lab SA
Glutenostics
NanoRepro
Thermo Fisher Scientific
Targeted Genomics
YorkTest
Biohit Oyj
Labsystems Diagnostics Oy
Biomerica
Smartblood
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Celiac Disease Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Celiac Disease Testing, with revenue, gross margin, and global market share of Celiac Disease Testing from 2020 to 2025.
Chapter 3, the Celiac Disease Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Celiac Disease Testing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Celiac Disease Testing.
Chapter 13, to describe Celiac Disease Testing research findings and conclusion.
Celiac disease is a digestive disorder that causes the body to have difficulty absorbing nutrients like fat, calcium, iron, and folate. It is an autoimmune disease in which gluten-containing foods cause damage to the small intestine lining.Celiac disease is diagnosed using a combination of serologic tests, small bowel biopsy, and a gluten-free diet response. Several serologic antibody tests can be used as initial tests. Antigliadin antibodies are no longer recommended for initial testing due to their low sensitivity and specificity.
The global celiac disease testing market refers to the market for diagnostic tests used to detect celiac disease, an autoimmune disorder where the body’s immune system reacts to gluten, a protein found in wheat, barley, and rye. Celiac disease can cause damage to the small intestine and lead to various symptoms, including gastrointestinal discomfort, malabsorption of nutrients, and other complications.
The market for celiac disease testing includes both laboratory-based tests and point-of-care (POC) tests. Laboratory-based tests involve analyzing blood samples for specific antibodies that are associated with celiac disease, such as anti-tissue transglutaminase (anti-tTG) antibodies, anti-endomysial antibodies (EMA), and anti-deamidated gliadin peptide (anti-DGP) antibodies. POC tests are designed to provide rapid and convenient results at the point of patient care, such as doctor’s offices or pharmacies.
The global celiac disease testing market is driven by several factors, including the increasing awareness and diagnosis of celiac disease, the growing demand for early and accurate detection, and the rising prevalence of the disease worldwide. According to the Celiac Disease Foundation, it is estimated that about 1% of the global population is affected by celiac disease.
In terms of geography, North America dominates the celiac disease testing market, followed by Europe. This can be attributed to the high awareness levels among healthcare professionals and patients, well-established healthcare infrastructure, and the presence of key market players in these regions. However, with increasing awareness and healthcare infrastructure development in emerging economies, such as China and India, the Asia-Pacific region is expected to witness substantial growth in the celiac disease testing market.
Key players in the global celiac disease testing market include diagnostic laboratories, healthcare providers, and companies specializing in diagnostic tests. These companies focus on developing innovative and accurate diagnostic tools for celiac disease, as well as providing comprehensive testing services. Additionally, research efforts are ongoing to discover new biomarkers and improve the efficiency and specificity of celiac disease testing.
Overall, the global celiac disease testing market is expected to experience significant growth in the coming years, driven by factors such as increasing awareness, improving diagnostic technologies, and rising global prevalence of celiac disease.
This report is a detailed and comprehensive analysis for global Celiac Disease Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Celiac Disease Testing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Celiac Disease Testing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Celiac Disease Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Celiac Disease Testing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Celiac Disease Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Celiac Disease Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PRIMA Lab SA, Glutenostics, NanoRepro, Thermo Fisher Scientific, Targeted Genomics, YorkTest, Biohit Oyj, Labsystems Diagnostics Oy, Biomerica, Smartblood, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Celiac Disease Testing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Serologic Tests
Genetic Tests
Intestinal Biopsies
Others
Market segment by Application
Hospitals
Diagnostic Laboratories
Home Care
Others
Market segment by players, this report covers
PRIMA Lab SA
Glutenostics
NanoRepro
Thermo Fisher Scientific
Targeted Genomics
YorkTest
Biohit Oyj
Labsystems Diagnostics Oy
Biomerica
Smartblood
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Celiac Disease Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Celiac Disease Testing, with revenue, gross margin, and global market share of Celiac Disease Testing from 2020 to 2025.
Chapter 3, the Celiac Disease Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Celiac Disease Testing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Celiac Disease Testing.
Chapter 13, to describe Celiac Disease Testing research findings and conclusion.
Table of Contents
84 Pages
- 1 Market Overview
- 2 Company Profiles
- 3 Market Competition, by Players
- 4 Market Size Segment by Type
- 5 Market Size Segment by Application
- 6 North America
- 7 Europe
- 8 Asia-Pacific
- 9 South America
- 10 Middle East & Africa
- 11 Market Dynamics
- 12 Industry Chain Analysis
- 13 Research Findings and Conclusion
- 14 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
